The results of this analysis revealed that factors such as age (≥60 years), lymph node metastasis, distant metastasis, T stage (T3 and T4 stage), TNM stage (stage III and stage IV), and high expression of TRIM32 in tumor tissues were all significantly correlated with the overall survival (OS) of patients (p < 0.05). Here, TRIM32 is linked to metastatic malignant neoplasm in the lymph nodes.